Physician profile
Carson S Webb
NPI 1053491019
$3,780.66
in general payments reported to CMS, 2019-2025
21 companies · $435 in 2025
The $435 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $45.69 · 2021: $433 · 2022: $815 · 2023: $908 · 2024: $763 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,087 · Education: $18.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,087.11 |
| Education | $18.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $952.35 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Inari Medical, INC. | $632.87 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $357.16 | 2020-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $326.54 | 2019-2024 | |
| Abiomed | $315.14 | 2023 | Impella |
| Boston Scientific Corporation | $247.54 | 2019-2025 | Watchman Access System |
| Merit Medical Systems INC | $225.13 | 2023-2025 | Prelude Introducers, Surecross Support Catheters, Basixcompak Inflation Device |
| Cardiovascular Systems INC. | $150.08 | 2019-2022 | |
| Astellas Pharma US INC | $99.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $88.27 | 2019-2021 | |
| Pfizer INC. | $72.43 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $58.96 | 2022-2025 | Verquvo |
| Ekos Corporation | $54.32 | 2019 | |
| Amgen INC. | $44.47 | 2019-2021 | |
| Amarin Pharma, INC. | $35.22 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $33.23 | 2019-2023 | Evkeeza |
| Medtronic, INC. | $23.96 | 2021 | |
| Braemar Manufacturing, LLC | $21.28 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.96 | 2022 | |
| Medtronic Vascular, INC. | $13.46 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.